CurrentRheuma coverage · page 23 of 48
Rheumatology (Oxford)
Latest from Rheumatology (Oxford)
Rheumatology (Oxford)
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: achievement of minimal disease activity components in a phase 2 trial
Secondary analysisSpondyloarthritis & PsA
Rheumatology (Oxford)
Rheumatology (Oxford)
FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis
Cohort studyVasculitis & PMR
Rheumatology (Oxford)
Rheumatology (Oxford)
Arthralgia with risk of progression to psoriatic arthritis: role of clinical assessments and ultrasound as prognostic factors
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL
Diagnostic or prognostic studySystemic sclerosis
Rheumatology (Oxford)
Autoantibodies towards HFE and SYT5 in anti-neutrophil cytoplasm antibody-associated vasculitis relapse
Research articleVasculitis & PMR
Rheumatology (Oxford)
Diffusion tensor imaging of vastus lateralis in patients with inflammatory myopathies
Cross-sectional studyMyositis
Rheumatology (Oxford)
Rheumatology (Oxford)
Association between colchicine use and adverse cardiovascular events in patients with gout: a nationwide nested case–control study
Case-control studyGout & crystals
Rheumatology (Oxford)
Vasculitis associated with VEXAS syndrome
Cohort studyAutoinflammatory & rare
Rheumatology (Oxford)
Impact of treatments on fatigue in axial spondyloarthritis: a systematic review and meta-analysis
Meta-analysisSpondyloarthritis & PsA
Rheumatology (Oxford)
Rheumatology (Oxford)
Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Demographics and clinical features associated with abnormal small bowel motility in systemic sclerosis
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Real-world outcomes of a dedicated fast-track polymyalgia rheumatica clinic
Cohort studyVasculitis & PMR
Rheumatology (Oxford)
Systemic inflammation in asymptomatic hyperuricaemia with sonographic crystal deposits, including a comparison with normouricaemia and gout
Cross-sectional studyGout & crystals
Rheumatology (Oxford)
Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritis
Cross-sectional studyRA
Rheumatology (Oxford)
Rheumatology (Oxford)
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry
Cohort studyAutoinflammatory & rare
Rheumatology (Oxford)
Rheumatology (Oxford)
Vessel wall MRI in giant cell arteritis: standardized protocol and scoring approach developed by an international working group
Guideline or statementVasculitis & PMR
Rheumatology (Oxford)
Diagnostic delay in patients from the International Map of Axial Spondyloarthritis: geographic, sociodemographic and disease-related factors
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)
Rheumatology (Oxford)
Diagnostic accuracy of hip joint ultrasound for detection of calcium pyrophosphate deposition
Diagnostic or prognostic studyGout & crystals
Rheumatology (Oxford)
Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)
Colour changes in the feet: a sign of autonomic symptoms in systemic sclerosis
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)